Abstract:1299 Since 1977, numerous studies have indicated the existence of a putative membrane-based estrogen receptor. However, the identity of this membrane-based estrogen receptor has not been established. Through an extensive homology search in Gene Bank, we recently identified and cloned a novel variant of ER-Α with a predicted molecular weight of 35.7 kDa. The transcript of this ER-Α variant is initiated from a previously unidentified promoter in the first intron of the original ER-Α gene. This ER-Α variant differs from the original ER-Α by lacking both transcriptional activation domains (AF-1 and AF-2) but retaining the dimerization, DNA-binding and partial ligand-binding domains. Its ligand-binding domain also possesses a unique 27 amino acid stretch that replaces the last 138 amino acids of the ER-Α. In transient transfection assays, this ER-Α variant exhibited no intrinsic transcriptional activity but strongly inhibited ligand-dependent and -independent transactivation activities mediated by the original ER-Α and ER-Β. Immunodetection and subcellular fractionation assays demonstrated that this ER-Α variant is expressed on the plasma membrane of mammary epithelial cells, and also in the cytoplasm and nucleus. In cells that express this ER-Α variant, 17Β-estradiol (E2) treatment activated a membrane-initiated effect of estrogen signaling by transiently activating the mitogen-activated protein kinase (MAPK) pathway that led to cell proliferation. Antiestrogens such as tamoxifen and ICI 182,780, however, strongly and persistently activated the MAPK pathway that then resulted in activation of the SAPK/JNK pathway. Immunohistochemistry analysis using a specific antibody aganst this ER-Α variant revealed that 26 of 38 cases (68%) breast cancer specimens examined express this ER-Αvariant on the plasma membrane and cytoplasm, and 12 out of 13 ER-negative breast caner specimens also express this ER-Α variant. Our findings demonstrate a physiologically important ER-Α variant that is involved in membrane-initiated estrogen signaling and suggest that aberrant expression of this ER-Α variant contributes to development of ER-positive and-negative human breast cancer.

Preliminary Study of Membrane Estrogen Receptor Expression in Endometrial Carcinoma Cells

Different Biological Effect of Estrogen Receptor-Related Receptor Α in Estrogen Receptor-Positive and -Negative Endometrial Carcinoma.

[Membrane-Initiated Nongenomic Effect on Mitogen-Activated Protein Kinase Signal Transduction of Estrogen in Endometrial Carcinoma Cell].

Expression of Estrogen Receptor-Related Receptor Isoforms in Endometrial Carcinoma Tissues and Its Clinical Significance

Expressions of Estrogen Receptor Α and Β in Endometrialcarcinoma Cell Lines, Ishikawa and HEC-1A

Expressions of estrogen receptor-related receptor alpha and estrogen receptors in endometrial carcinoma

A novel variant of estrogen receptor-alpha is expressed in ER-negative breast cancer and mediates membrane-initiated estrogen signaling

[Expression of Estrogen Receptor-Related Receptor Alpha and Estrogen Receptor Alpha in Endometrial Carcinoma and the Primary Investigation of Their Clinical Significance].

Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells.

[Regulatory Effect of 17Beta-Estradiol on Expression of Orphan Nuclear Receptor ERRalpha in Endometrial Carcinoma Cell Lines].

Expression of Estrogen and Progesterone Receptor Subtypes in Human Endometrial Carcinoma Tissues

An Estrogen Receptor ?-Dependent Regulation of Estrogen Receptor?related Receptor ? in the Proliferation of Endometrial Carcinoma Cells

A primary study on the expression of estrogen receptor α36 in endometrial carcinoma tissues

Expression of ER-α36, a novel variant of estrogen receptor in endometrial carcinoma and its clinical significance.

Modulation and function of estrogen receptor isoforms alpha and beta in endometrial carcinoma cells]

[Regulation of 17Beta-E2 on the Membrane Estrogen Receptor Alpha].

Expression and Correlation of Vascular Endothelial Growth Factor and Estrogen Receptor in Endometrial Carcinomas

[Regulation of Orphan Receptor ERR Alpha by Estrogen and Progesterone in Endometrial Carcinoma Cell Line].

Regulation of 17Β-E2 on the Membrane Estrogen Receptor Α

[Expression of Receptor-Binding Cancer Antigen Expressed on SiSo Cells in Endometrial Carcinoma and the Correlation Thereof with the Expression of Estrogen Receptor Subtypes].

Expression of Estrogen Receptor-Related Receptor Isoforms and Clinical Significance in Endometrial Adenocarcinoma